Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Lamm

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
CA: a Cancer Journal for Clinicians|September 1, 1990
Cancer statisticsD L Lamm
Cancer Surveys|July 30, 2004
Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?D L Lamm
European Urology|January 1, 1992
Optimal BCG treatment of superficial bladder cancer as defined by American trialsD L Lamm
The Journal of Urology|August 23, 2000
The challenge of improved diagnostic and prognostic indicators of superficial bladder cancerD L Lamm
European Urology|January 1, 1995
Advances in the treatment of superficial bladder cancer: optimizing BCG immunotherapy. IntroductionD L Lamm
The Journal of Urology|July 1, 1985
Bacillus Calmette-Guerin immunotherapy for bladder cancerD L Lamm
Urology|January 1, 1991
Comparison of BCG with other intravesical agentsD L Lamm
The Journal of Urology|August 1, 1987
Bacillus Calmette-Guerin immunotherapyD L Lamm
The Journal of Urology|June 1, 1992
Re: Transitional cell carcinoma of the prostateD L Lamm
Anti-Cancer Drugs|May 1, 1992
Diagnosis and treatment of bladder cancerD L Lamm
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
CA: a Cancer Journal for Clinicians|September 1, 1990
Cancer statisticsD L Lamm
Cancer Surveys|July 30, 2004
Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?D L Lamm
European Urology|January 1, 1992
Optimal BCG treatment of superficial bladder cancer as defined by American trialsD L Lamm
The Journal of Urology|August 23, 2000
The challenge of improved diagnostic and prognostic indicators of superficial bladder cancerD L Lamm
European Urology|January 1, 1995
Advances in the treatment of superficial bladder cancer: optimizing BCG immunotherapy. IntroductionD L Lamm
The Journal of Urology|July 1, 1985
Bacillus Calmette-Guerin immunotherapy for bladder cancerD L Lamm
Urology|January 1, 1991
Comparison of BCG with other intravesical agentsD L Lamm
The Journal of Urology|August 1, 1987
Bacillus Calmette-Guerin immunotherapyD L Lamm
The Journal of Urology|June 1, 1992
Re: Transitional cell carcinoma of the prostateD L Lamm
Anti-Cancer Drugs|May 1, 1992
Diagnosis and treatment of bladder cancerD L Lamm
Pageof 14